Quantcast

Latest Lilly Stories

2014-03-31 20:22:46

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta(®) (pemetrexed for injection). In the case of Eli Lilly and Company v. Teva Parenteral Medicines Inc., et al., the court ruled the vitamin dosage regimen patent is valid and enforceable. The patent provides intellectual property protection...

2014-03-26 08:26:19

Revlon Global Brand Ambassadors Halle Berry & Emma Stone, along with Christina Applegate to Host 2014 Events in New York City on May 3rd & Los Angeles on May 10th LOS ANGELES, March 26, 2014 /PRNewswire-USNewswire/ -- Revlon (NYSE: REV), The Entertainment Industry Foundation (EIF) and Lilly Tartikoff are proud to announce the 21(st) annual EIF Revlon Run/Walk for Women. Revlon Brand Ambassador Emma Stone will host the 2014 event in New York on Saturday, May 3(rd )and Revlon Brand...

2014-03-05 16:26:36

INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 12, 2014. David Ricks, Lilly senior vice president, and president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00 p.m. EDT. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the fireside...

2014-03-05 12:26:22

Boehringer Ingelheim and Lilly are committed to working with the FDA RIDGEFIELD, Conn. and INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. The complete response letter...

2014-02-24 08:28:13

Deal Provides Elanco with a Leading Poultry Vaccine Portfolio and Manufacturing Capabilities GREENFIELD, IN, Feb. 24, 2014 /PRNewswire/ -- Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately-held company headquartered in Cuxhaven, Germany. Lohmann Animal Health is a global leader in the supply of poultry vaccines and also markets a range of feed additives. The acquisition will...

2014-02-21 12:24:54

INDIANAPOLIS, Feb. 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will attend the 34(th) Annual Cowen and Company Healthcare Conference on Tuesday, March 4, 2014. Derica Rice, Lilly executive vice president, global services, and chief financial officer, will participate in a fireside chat at 11:20 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a...

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-02-05 16:30:56

JourneyEd.com and AcademicSuperStore.com are now under new ownership, and the conjoined education company is making significant changes to its customer experience DALLAS, Feb. 5, 2014 /PRNewswire/ -- JourneyEd.com and AcademicSuperStore.com are now under new ownership. Greg Lamkin is the new CEO, while Tim Lilly fills the role of president, and the consolidated company will be named JourneyEd.com, Inc. Greg Lamkin has been with JourneyEd.com for over 10 years, beginning as a...

2014-02-05 16:27:52

INDIANAPOLIS, Feb. 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Swann Global Healthcare Conference on Wednesday, February 12, 2014. Jan M. Lundberg, Ph.D., executive vice president of science and technology and president of Lilly Research Laboratories, will discuss Lilly's pipeline in a fireside chat at 8:25 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at...

2014-01-31 12:25:16

INDIANAPOLIS, Jan. 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent infringement with respect to LY2963016, a new insulin glargine product for which Lilly is currently seeking approval from the U.S. Food and Drug Administration (FDA). "Lilly respects the intellectual property of others and does not believe the...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related